Aarti Drugs Ltd. (AARTIDRUGS)
Market Closed
15 Oct, 10:00 AM
XNSE XNSE Primary MSE ₹
396. 45
-4.15
-1.0359%
₹
41.5B Market Cap
- P/E Ratio
4% Div Yield
78,405 Volume
- Eps
₹ 400.6
Previous Close Want to track AARTIDRUGS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aarti Drugs Ltd. (AARTIDRUGS) Statistics
Valuation metrics
Market Cap 41.5B
Enterprise value 43.4B
Trailing P/E (ttm) 19.74
Forward P/E -
PEG ratio 15.7
Price/Sales (ttm) 1.41
Price/Book (mrq) 2.44
Enterprise Value/Revenue 1.62
Enterprise Value/EBITDA 12.99
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 149.38K
Average volume (90 days) 197.16K
Price summary
52-Week low 318.95
52-Week high 534
Beta -
50-Day moving average 424.39
200-Day moving average 395.16
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 2
Trailing annual dividend yield 0.0048%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 4 Mar 2026
Ex-Dividend Date 9 Feb 2026
Last split factor 4:1
Last split Date 30 Sep 2020
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.07%
Operating margin 0.1%
Operational effectiveness
Return on assets 0.07%
Return on equity 0.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 293.37
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 20.95
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.66
Total debt (mrq) -
Total Debt/Equity (mrq) 0.37
Current ratio (mrq) 1.59%
Book value per share (mrq) 169.74
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
